HBTA vs. MEDX
HBTA (Horizon Expedition Plus ETF) and MEDX (Horizon Kinetics Medical ETF) are both exchange-traded funds - HBTA is a Derivative Income fund actively managed by Horizon, while MEDX is a Health & Biotech Equities fund actively managed by Horizon. Both are actively managed. Over the past year, HBTA returned 38.33% vs 29.45% for MEDX. At a 0.32 correlation, their price movements are largely independent. Both charge a 0.85% expense ratio.
Performance
HBTA vs. MEDX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HBTA achieves a 14.07% return, which is significantly higher than MEDX's 0.84% return.
HBTA
- 1D
- -0.68%
- 1M
- 7.20%
- YTD
- 14.07%
- 6M
- 14.43%
- 1Y
- 38.33%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MEDX
- 1D
- 0.92%
- 1M
- 2.85%
- YTD
- 0.84%
- 6M
- 0.03%
- 1Y
- 29.45%
- 3Y*
- 5.77%
- 5Y*
- —
- 10Y*
- —
HBTA vs. MEDX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
HBTA Horizon Expedition Plus ETF | 14.07% | 14.69% |
MEDX Horizon Kinetics Medical ETF | 0.84% | 25.90% |
Correlation
The correlation between HBTA and MEDX is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jan 24, 2025 | 0.32 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HBTA vs. MEDX — Risk / Return Rank
HBTA
MEDX
HBTA vs. MEDX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Horizon Expedition Plus ETF (HBTA) and Horizon Kinetics Medical ETF (MEDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HBTA | MEDX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.59 | ||
| Sortino ratioReturn per unit of downside risk | +0.39 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.29 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 2.92 | 2.81 | +0.12 |
| Martin ratioReturn relative to average drawdown | 13.75 | 7.81 | +5.94 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HBTA | MEDX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.24 | 1.65 | +0.59 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.91 | 0.27 | +0.64 |
Drawdowns
HBTA vs. MEDX - Drawdown Comparison
The maximum HBTA drawdown since its inception was -26.73%, which is greater than MEDX's maximum drawdown of -23.10%. Use the drawdown chart below to compare losses from any high point for HBTA and MEDX.
Loading charts...
Drawdown Indicators
| HBTA | MEDX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.73% | -23.10% | -3.63% |
Max Drawdown (1Y)Largest decline over 1 year | -13.18% | -10.54% | -2.64% |
Max Drawdown (3Y)Largest decline over 3 years | — | -23.10% | — |
Current DrawdownCurrent decline from peak | -0.68% | -5.55% | +4.87% |
Average DrawdownAverage peak-to-trough decline | -4.22% | -6.72% | +2.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.80% | 3.78% | -0.98% |
Volatility
HBTA vs. MEDX - Volatility Comparison
The current volatility for Horizon Expedition Plus ETF (HBTA) is 4.46%, while Horizon Kinetics Medical ETF (MEDX) has a volatility of 4.92%. This indicates that HBTA experiences smaller price fluctuations and is considered to be less risky than MEDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HBTA | MEDX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.46% | 4.92% | -0.46% |
Volatility (6M)Calculated over the trailing 6-month period | 13.24% | 13.08% | +0.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.18% | 17.88% | -0.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.85% | 16.97% | +7.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.85% | 16.97% | +7.88% |
HBTA vs. MEDX - Expense Ratio Comparison
Both HBTA and MEDX have an expense ratio of 0.85%.
Dividends
HBTA vs. MEDX - Dividend Comparison
HBTA's dividend yield for the trailing twelve months is around 0.56%, less than MEDX's 1.22% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
HBTA Horizon Expedition Plus ETF | 0.56% | 0.64% | 0.00% | 0.00% |
MEDX Horizon Kinetics Medical ETF | 1.22% | 1.23% | 1.92% | 4.94% |
Frequently Asked Questions
HBTA and MEDX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MEDX has higher volatility (4.92%) compared to HBTA (4.46%). In terms of maximum drawdown, HBTA dropped -26.73% vs MEDX's -23.10%.
On 1-year performance, HBTA leads with 38.33% vs 29.45% for MEDX. Both ETFs have the same 0.85% expense ratio. On volatility, HBTA has been the lower-risk option at 4.46%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, HBTA has performed better with a 38.33% return vs 29.45%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HBTA and MEDX have the same expense ratio: 0.85% per year.
MEDX has the higher dividend yield at 1.22%, compared with 0.56% for HBTA.
HBTA is categorized as Derivative Income, while MEDX is Health & Biotech Equities.
HBTA currently has the higher Sharpe Ratio (2.24 vs 1.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HBTA and MEDX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer